Collegium Pharmaceutical (COLL) PT Raised to $36 at Needham & Company on Updated Guidance, Immediate Synergies with BDSI
Tweet Send to a Friend
Needham & Company analyst Serge Belanger raised the price target on Collegium Pharmaceutical (NASDAQ: COLL) to $36.00 (from $34.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
